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Abstract
Background: Radiotherapy is routinely used in the treatment of pelvic malignancies and about 2–5% of these patients 
develop radiation-induced proctitis or proctocolitis. This complication of radiotherapy is treated in different ways. 
Two of these treatments, argon plasma coagulation (APC) and formalin instillation, have both been reported as to be 
successful modalities, but data comparing them are scarce. We conducted this study to compare these two treatment 
options.
Methods: We reviewed the charts of patients who had radiation-induced proctocolitis and who were treated 
endoscopically at our tertiary care cancer centre with either APC or formalin instillation. Outcomes of the two 
treatments were compared in terms of bleeding control after the first session of treatment, the number of sessions 
required and the final response to therapy.
Results: Out of a total of 26 patients presenting with haemorrhagic radiation proctocolitis, 11 were treated with APC 
and 15 with formalin instillation. Success after the first session was 53% in the formalin instillation group compared to 
18% in the APC-treated group. On repeated sessions, the final response to both treatment modalities was comparable.
Conclusion: Efficacy of APC and formalin instillation in the treatment of haemorrhagic radiation proctocolitis is 
comparable although formalin showed a better outcome after the first session.
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Introduction
Radiation-induced proctitis or proctocolitis is a 
complication of radiotherapy used to treat pelvic 
malignancies, especially prostate cancer, in which its 
occurrence is reported to be as high as 80%.[1] The 
presentation of radiation-induced proctocolitis varies.
Symptoms include urgency, diarrhoea, tenesmus, rectal 
pain and bleeding per rectum.
On endoscopy, multiple telangiectatic vessels are found 
which bleed to touch. Histopathology in the initial phase 
shows damaged vascular endothelium, but later, mucosal 
ulcers and neovascularisation are found. In cases of 
severe disease, extensive fibrosis, fistulas and strictures 
can be seen. Rupture of telangiectatic vessels and oozing 
from friable ischaemic mucosa leads to haemorrhagic 
manifestations of the disease. A range of options is 
available for the treatment of this condition including 
hyperbaric oxygen, sucralfate enemata, 5-aminosalicylic 
acid and steroid enemata as medical therapies while 
among endoscopic options, argon plasma coagulation 
(APC), formalin instillation and Nd: YAG laser are 
currently available.[2-5] Surgical treatment options include 
defunctioning colostomy and resection of affected 
colon. All of these options have both advantages and 
disadvantages.
In APC, ignition of argon gas is used to coagulate the 
telangiectatic vessels. A success rate of 81% has been 
reported with APC in haemorrhagic radiation proctitis.[6] 
Formalin instillation was described in the late 1960s 
JOURNAL OF CANCER & ALLIED SPECIALTIES 2
ORIGINAL ARTICLE J Cancer Allied Spec 2015;1(1):4
for the treatment of haemorrhagic cystitis. It works by 
sclerosing the telangiectatic vessels and thus controls 
bleeding. The same mechanism is used in the treatment 
of radiation-induced proctocolitis.[7] There are scarce data 
available regarding the comparison of these endoscopic 
modalities of treatment for haemorrhagic proctocolitis. 
The aim of this study was to compare these two treatment 
options in terms of outcomes.
Methods
Setting
This study was carried out at Shaukat Khanum Memorial 
Cancer Hospital and Research Centre (SKMCH and RC), 
a 189-bed cancer tertiary care cancer centre in Lahore, 
Pakistan. This study was approved by the Institutional 
Review Board of SKMCH and RC. We reviewed the 
charts of all patients who underwent endoscopic treatment 
for bleeding per rectum and were diagnosed as having 
radiation-induced injury at our institution between 2008 
and 2013. All endoscopies were performed by one of two 
experienced endoscopists. All procedures were carried out 
under conscious sedation, using midazolam. One group 
of patients was treated with APC. We used the VIO 200 S 
ERBE argon plasma coagulator (Germany), with an end-
firing probe, 2.7–3.2 mm in size. Argon gas flow was 
2 L/min and the electrical power settings were 20–30 W. 
All the telangiectatic vessels were treated in a single 
session and painting of the entire mucosa was avoided as 
far as possible. All the visible lesions on the forward view 
were treated first and then the procedure was repeated in 
retroflexion. The other group was treated with formalin 
instillation. 60 ml of 5% formalin was used in each patient, 
20 ml in each position i.e., left lateral, supine and right 
lateral. Contact time was 2 min in each position. Patients 
were managed on an outpatient basis and were asked to 
follow-up in case of persistence of bleeding. Follow-
up was completed by a review of medical records. We 
collected demographic data of all the patients who were 
diagnosed with radiation-induced proctitis, proctocolitis 
or colitis at endoscopy and the severity of their disease 
was graded by review of photographs and videos of the 
lesions. We categorised lesions into Grade 1 if there 
was a single lesion, Grade 2 if there were multiple but 
non-confluent lesions and Grade 3 if there were multiple 
confluent lesions. We compared the APC and formalin 
groups for a response after the first session, calculated the 
total number of sessions, whether alternative treatments 
were used and the final outcome in terms of success or 
failure of endoscopic treatment in controlling bleeding 
post-therapy.
Results
We saw a total of 26 patients with haemorrhagic 
proctocolitis. The mean age of patients in this cohort 
was 57 ± 11 years. 17 (65.4%) patients were females. 
Radiotherapy was used in the treatment of cervical cancer 
in 12 (46%), of prostate cancer in 6 (23%), of endometrial 
cancer in 4 (15%), carcinoma of the anal canal in 2 (8%) and 
bladder carcinoma in 2 (8%). The mean duration from the 
end of radiotherapy to the presentation with haemorrhagic 
proctocolitis was 11 months (range 4–21 months). On 
endoscopy, 14 (53.8%) had inflammation limited to the 
rectum (proctitis), 7 (27%) had colitis and 5 (19.2%) 
had proctocolitis. 11 patients were treated with APC and 
15 with formalin instillation as the first modality. 82% 
(9/11) patients in the APC group and 80% (12/15) in the 
formalin group had Grade 3 disease. Successful cessation 
of haemorrhagic manifestations without any recurrence 
was seen in 8/15 (53%) patients in the formalin instillation 
group and in 2/11 (18%) patients in the APC group. None 
of the patients in the formalin instillation group required 
more than 2 sessions of treatment. The median number of 
sessions in the APC group was 2 (range: 1–4) while in the 
formalin instillation group the median number of sessions 
was 1 (range: 1–2). Alternate or additional therapy was 
used in eight patients, four from each group. Alternate 
therapy included formalin instillation in three and steroid 
enemata in one patient in the APC group. Formalin therapy 
was instituted after a single unsuccessful session of APC 
in 2 patients and after three sessions in 1 patient. None 
of the patients received an alternate therapy before or 
during the first session of APC. Alternate therapies in the 
formalin instillation group were oral mesalazine in two 
patients, steroid enema in one and sucralfate enema in one 
patient. None of the patients in the formalin group had 
APC, despite the failure of the primary modality. Finally, 
18 patients had successful medical therapy to control 
the haemorrhagic manifestations of radiation-induced 
proctocolitis, while one required surgical treatment. 
Others resolved spontaneously, later, but not within 
2 weeks of therapy.
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Discussion
Radiation-induced injuries are not uncommon in pelvic 
malignancies treated with radiotherapy. Successful 
management of bleeding, as well as other symptoms of 
radiation-induced proctocolitis, is challenging. There 
are multiple options available, but the superiority of one 
over the other is not yet established and it is usually the 
endoscopist’s preference as to which modality to employ. 
Most studies of the various treatment options have 
reported partial success. These options include sucralfate 
enemata, steroid enemata, sulfasalazine, 5-ASA, either 
orally or as an enema, APC, formalin instillation and 
Nd: Yag laser.[8] Recently, hyperbaric oxygen therapy 
has been shown to have promising results but its cost and 
limited availability limits its use.[9] All of these treatment 
options have their advantages and disadvantages.
APC is cost-effective, widely-available, relatively easy to 
learn and apply and has a low risk of complications. Its 
mechanism involves the application of bipolar diathermy 
current which is conducted by argon gas through the 
APC catheter. It has a limited and predictable depth of 
coagulation which makes it safe.[10] However, it often 
requires multiple sessions to control bleeding and is 
associated with a risk of stricture formation and persistent 
ulceration.[11,12] Previous studies have shown response rates 
of 80–90% in haemorrhagic proctocolitis when treated with 
repeated sessions of APC. None of these studies assessed 
the first session response, however. One of the reasons 
for the low overall success rate in our study as compared 
to previous studies is a lower number of treatment 
sessions. Our median number of sessions was two while 
in previous studies, up to eight sessions of therapy have 
been reported.[11,12] Complication rates with APC have 
been quite variable in previous studies. One study reports 
post-procedure pain in 20%, and severe complications 
such as excessive bleeding, necrosis and perforation in 
3% of patients.[13] No symptomatic complications were 
seen in our cohort, but we cannot rule out the possibility 
of asymptomatic complications as follow-up colonoscopies 
were not performed routinely. A possible reason for the 
absence of overt complications in our study could be 
the low power settings (20–30 W compared to 50–60 W 
reported in other studies) used for AOC at our institution. 
This has previously been associated with a low incidence 
of complications.[13] The same factor could be responsible 
for the lower success rate of our procedures. We could not 
find any data that compared the success rate of APC at 
Table of comparison between two groups
Patients APC group Formalin instillation group P‑value
Number of patients 11 15
Mean age 61 54.2
Gender 0.87
Males 4 (36.4%) 5 (33.3%)






Grade 3 9 (82%) 12 (80%)
Grade 2 2 (18%) 2 (13%) 0.65
Grade 1 00 1 (7%)
Mean no of sessions 1.81 1.4
Median no of sessions 2 1 0.06
Responders after first session 2 (18%) 8 (53%)
Number of patients requiring alternate therapy 4 4 0.33
Final responders 9 (81%) 10 (67%)
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different power settings. Similarly, there are very few data 
on the comparison of APC with formalin instillation and the 
role of adjuvant medical measures, such as pharmacologic 
agents given as enemata in radiation-induced proctocolitis. 
In previous studies, APC was used mainly after the failure 
of medical measures, but we used it before any other 
measure followed by alternative therapies in failed cases. 
The use of formalin instillation is derived from its use in 
haemorrhagic cystitis. There were initial reports of the use 
of formalin soaked gauze for haemorrhagic proctocolitis, 
which later led to its use by endoscopic instillation. The 
success rate of formalin instillation has been reported to be 
as high as 60% in previous studies.[14] We also reported a 
success rate of 53% after the first session of the procedure, 
which is similar to previous studies.
There is no prospective trial available in literature comparing 
the APC with other endoscopic treatment modalities in 
haemorrhagic proctocolitis. There is only one study which 
compares APC with formalin instillation and this shows 
APC to be much more effective (78.5%) than formalin 
instillation (27.2%) in control of bleeding.[15] However, our 
study differs in APC settings and formalin dosage and in 
the fact that symptomatic relief has been used as a primary 
measure of outcome. A previous study had used a 10% rise 
in haemoglobin as a primary outcome measure, which might 
well be achieved with only partial control of bleeding.
Conclusion
APC and formalin instillation are effective options to 
control the haemorrhagic manifestations of radiation-
induced proctocolitis. Formalin instillation appears more 
effective in terms of first session response, but after 
multiple sessions, the success rates with both treatment 
modalities are comparable.
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